(Q36577542)

15 August 2017

1 reference

title

Mechanisms of disease: Transcription factors in inflammatory arthritis (English)

1 reference

15 August 2017

Dee Aud

1

1 reference

15 August 2017

Stanford L Peng

series ordinal

2

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

434-442

1 reference

Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

Signal transduction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Delineating the genetic basis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Transcription factors in the pathogenesis of autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

RANKL and RANK as novel therapeutic targets for arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

AP-1 as a regulator of cell life and death

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Roles for NF-kappaB and c-Fos in osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

NFAT proteins: key regulators of T-cell development and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Regulation of the symmetry and intensity of immune complex-mediated synovitis by nuclear factor of activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Forkhead transcription factors in immunology.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Molecular mechanisms regulating Th1 immune responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Transcription factors as potential targets for therapeutic drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Immunophilins: switched on protein binding domains?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

The signaling adaptors and pathways activated by TNF superfamily

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Modulation of Toll-interleukin 1 receptor mediated signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B Expression and binding to the 3'-IgH enhancer in B cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Manipulating immune responses with immunosuppressive agents that target NFAT.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Identification of JAK/STAT signalling components by genome-wide RNA interference.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0222

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0222

1 reference

15 August 2017

1 reference